German stocks - Factors to watch on June 17

Reuters2021-06-17

BERLIN/FRANKFURT, June 17 (Reuters) - The following are some of the factors that may move German stocks on Thursday:

CORONAVIRUS

Germany reported 1,330 new infections and 105 more deaths.

CUREVAC

German biotech CureVac NV said on Wednesday its COVID-19 vaccine was only 47% effective in a late-stage trial, missing the study's main goal and throwing in doubt the potential delivery of hundreds of millions of doses to the European Union.

MORPHOSYS AG

Morphosys said it had started a cash tender offer for all outstanding shares of Constellation Pharmaceuticals Inc. for $34.00 per share.

Suedzucker

Europe's largest sugar producer, on Wednesday reported lower first-quarter earnings due to the coronavirus pandemic, but said it remained optimistic profits will rise in its full financial year.

TESLA

Germany's transport minister is trying to convince Tesla to open its network of superchargers to other carmakers to make it easier for drivers of electric vehicles to charge.

COMMERZBANK

The lender said it had appointed Bettina Orlopp as deputy chairman.

BEFESA

Befesa said on Wednesday it would buy American Zinc Recycling $(AZR.SI)$ for $450 million to become a leader in recycling of steelmaking dust in Europe, Asia and the United States.

ANNUAL GENERAL MEETINGS

VARTA - 2.48 eur/shr dividend proposed

HOME24 - 0 eur/shr dividend proposed

OVERSEAS STOCK MARKETS

Dow Jones -0.8%, S&P 500 -0.5%, Nasdaq -0.2% at close.

Nikkei -1.1%, Shanghai stocks +0.2%.

Time: 4:25 GMT

ECONOMY

European May passenger car registration due at 0600 GMT.

DIARIES

REUTERS TOP NEWS

(Reporting by Berlin, Frankfurt and Gdansk newsrooms)

((frankfurt.newsroom@thomsonreuters.com; +49 30 2888 5169))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
1